References
- Schuttler CG, Caspari G, Jursch CA, Willems WR, Gerlich WH, Schaefer S. Hepatitis C virus transmission by a blood donation negative in nucleic acid amplification tests for viral RNA. Lancet 2000;355:41–2.
- Busch MP, Kleinman SH, Jackson B, Stramer SL, Hewlett I, Preston S. Committee report. Nucleic acid amplification testing of blood donors for transfusion-transmitted infectious diseases: report of the Interorganizational Task Force on Nucleic Acid Amplification Testing of Blood Donors. Transfusion 2000;40:143–59.
- Coste J, Reesink HW, Engelfriet CP, Laperche S, Brown S, Busch MP, et al. Implementation of donor screening for infectious agents transmitted by blood by nucleic acid technology: update to 2003. Vox Sang 2005;88:289–303.
- Harritshoj LH, Dickmeiss E, Hansen MB, Ullum H, Jorgensen LB, Gerstoft J. Transfusion-transmitted human immunodeficiency virus infection by a Danish blood donor with a very low viral load in the preseroconversion window phase. Transfusion 2008;48:2026–8.
- Loe Wiig F. To fikk blod fra Hepatitt C-smittet giver. Available at: http://www.nito.no/Fagmiljoer/Bioingeniorfaglig-institutt/Bioingenioren/Alle-Bioingeniorene/Bioingenioren-2011/Bioingenioren-10-20111/To-fikk-blod-fra-Hepatitt-C-smittet-giver-/ (accessed 7 October 2011).
- Duberg A, Janzon R, Back E, Ekdahl K, Blaxhult A. The epidemiology of hepatitis C virus infection in Sweden. Euro Surveill 2008;13. pii: 18882.
- Lagging M, Duberg AS, Wejstal R, Weiland O, Lindh M, Aleman S, et al. Treatment of hepatitis C virus infection in adults and children: updated Swedish consensus recommendations. Scand J Infect Dis 2012;44:502–21.
- Davidson T, Ekermo B, Gaines H, Lesko B, Akerlind B. The cost-effectiveness of introducing nucleic acid testing to test for hepatitis B, hepatitis C, and human immunodeficiency virus among blood donors in Sweden. Transfusion 2011; 51:421–9.
- Widell A, Elmud H, Persson MH, Jonsson M. Transmission of hepatitis C via both erythrocyte and platelet transfusions from a single donor in serological window-phase of hepatitis C. Vox Sang 1996;71:55–7.
- Transfusionsmedicin SFF. Blodverksamheten i Sverige 2011: omfattning, kvalitet och säkerhet. Available at: http://www.transfusion.se/wp-content/uploads/2012/08/Blodverksamheten-i-Sverige-2011.pdf (accessed 27 July 2012).
- Socialstyrelsen. Senaste version av SOSFS 2009:28 Socialstyrelsens föreskrifter om blodverksamhet. Available at: http://www.socialstyrelsen.se/sosfs/2009-28/ (accessed 1 April 2010).
- Weusten J, Vermeulen M, van Drimmelen H, Lelie N. Refinement of a viral transmission risk model for blood donations in seroconversion window phase screened by nucleic acid testing in different pool sizes and repeat test algorithms. Transfusion 2011;51:203–15.
- European Pharmacopoeia 5.0. 5th ed. European Directorate for the Quality of Medicines (EDQM), Council of Europe: Strasbourg; 2005. http://lib.njutcm.edu.cn/yaodian/ep/EP5.0/16_monographs/monographs_d-k/Human%20plasma%20for%20fractionation.pdf
- Alsio A, Jannesson A, Langeland N, Pedersen C, Farkkila M, Buhl MR, et al. Early quantification of HCV core antigen may help to determine the duration of therapy for chronic genotype 2 or 3 HCV infection. Eur J Clin Microbiol Infect Dis 2012;31:1631–5.
- Park Y, Lee JH, Kim BS, Kim DY, Han KH, Kim HS. New automated hepatitis C virus (HCV) core antigen assay as an alternative to real-time PCR for HCV RNA quantification. J Clin Microbiol 2010;48:2253–6.
- Medici MC, Furlini G, Rodella A, Fuertes A, Monachetti A, Calderaro A, et al. Hepatitis C virus core antigen: analytical performances, correlation with viremia and potential applications of a quantitative, automated immunoassay. J Clin Virol 2011;51:264–9.